In this part, we studied the association with the expression level of ACE2 and different clinical characteristics in order to better understand the relevance and mechanisms of the expression level of ACE2 in cancers, especially in different clinical stages of breast cancer and ovarian cancer patients. This evidence concerns the gene ACE2 and cancer.